The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Safety · Contraindications · continued

Pregnancy as an absolute contraindication posts 61–90

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

CC
c.chowdhuryTL2 Moderator19 May 2025#61

Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative contraindication depending on baseline severity.

0 likes 14mo
B
batchlogTL319 May 2025#62
DF
d.ferreiraTL2 Moderator19 May 2025#63

Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with caution, not avoided.

8 likes 14mo
BV
bias_varianceTL4Biostatistician19 May 2025#64
k.ogunleye, post #10: I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient. Go to post

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

2 likes in reply to #10 14mo
SO
s.ostergaardTL2 Moderator19 May 2025#65

Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.

0 likes 14mo
IT
impurity_tableTL3Analytical chemist19 May 2025#66

Severe renal impairment (eGFR <15): these compounds are renally cleared and accumulate in severe kidney disease. Risk-benefit is unfavourable without dose adjustment.

20 likes 14mo
IN
i.norgaardTL2 Moderator19 May 2025#67

On post #63 — agreed on the reasoning, with one qualification.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

5 likes 14mo
CR
compounding_ruthTL4Pharmacist19 May 2025#68
p.lindqvist, post #4: Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the standard approach. Go to post

Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the standard approach.

0 likes in reply to #4 14mo
EB
e.bakkenTL2 Moderator19 May 2025#69

I read post #67 twice before replying, because I had assumed the opposite.

Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative contraindication requiring specialist input.

2 likes 14mo
F
FConsidineTL1Member19 May 2025#70

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

0 likes 14mo
MC
m.coelhoTL2 Moderator19 May 2025#71
compounding_ruth, post #68: Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the standard approach. Go to post

post #70 answers the question as asked. The question underneath it is different.

Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people with baseline retinopathy.

10 likes in reply to #68 14mo
BS
b.solbergTL2 Moderator19 May 2025 · edited#72

History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not absolute, but requires monitoring.

22 likes 14mo
HM
h.mbekiTL2 Moderator19 May 2025#73

Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative contraindication depending on baseline severity.

0 likes 14mo
KR
k.radichTL2 Moderator19 May 2025#74

Coming back to post #72, because the follow-up matters more than the original answer.

Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants caution.

3 likes 14mo
CD
cannula_driftTL3Regular19 May 2025#75
bias_variance, post #64: For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

post #74 is right about the mechanism and I think understates the practical bit.

Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough to exclude this population.

15 likes in reply to #64 14mo
AM
a.mwangiTL2 Moderator19 May 2025#76
h.bhattacharya, post #6: This follows post #3 rather than contradicting it. Severe renal impairment (eGFR Go to post

Worth separating two things that post #72 runs together.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

29 likes in reply to #6 14mo
B
BGiordanoTL2Member20 May 2025#77

Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative contraindication depending on baseline severity.

0 likes 14mo
BV
b.vestergaardTL2 Moderator20 May 2025#78

Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with caution, not avoided.

5 likes 14mo
NS
n.silvaTL2 Moderator20 May 2025#79

Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the standard approach.

3 likes 14mo
MH
ms_hollowayTL4Mass spectrometrist20 May 2025#80
e.halonen, post #31: Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative contraindication depending on baseline severity. Go to post

On post #76 — agreed on the reasoning, with one qualification.

Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative contraindication requiring specialist input.

10 likes in reply to #31 14mo
GP
g.pemberton_ukTL3Regional · UK20 May 2025#81

On post #77 — agreed on the reasoning, with one qualification.

Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough to exclude this population.

0 likes 14mo
RS
r.szaboTL220 May 2025#82
CR
crossover_reviewTL3Regular20 May 2025#83
GEldridge, post #24: I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient. Go to post

Severe renal impairment (eGFR <15): these compounds are renally cleared and accumulate in severe kidney disease. Risk-benefit is unfavourable without dose adjustment.

12 likes in reply to #24 14mo
AV
ai.vukovicTL2 Moderator20 May 2025#84
h.bhattacharya, post #6: This follows post #3 rather than contradicting it. Severe renal impairment (eGFR Go to post

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

4 likes in reply to #6 14mo
MM
methods_marginTL3Regular20 May 2025#85

History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not absolute, but requires monitoring.

0 likes 14mo
KB
k.batistaTL2 Moderator20 May 2025 · edited#86

post #85 is right about the mechanism and I think understates the practical bit.

Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people with baseline retinopathy.

19 likes 14mo
ST
stopper_traceTL2Member20 May 2025#87

I read post #85 twice before replying, because I had assumed the opposite.

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

8 likes 14mo
MG
m.guerreroTL2 Moderator20 May 2025#88
ai.vukovic, post #84: I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient. Go to post

Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.

2 likes in reply to #84 14mo
KO
k.otieno_statsTL3Statistician20 May 2025#89
buffer_review, post #5: I read post #3 twice before replying, because I had assumed the opposite. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment. Go to post

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

1 like in reply to #5 14mo
JM
j.moreauTL2 Moderator20 May 2025#90

Severe renal impairment (eGFR <15): these compounds are renally cleared and accumulate in severe kidney disease. Risk-benefit is unfavourable without dose adjustment.

0 likes 14mo